# Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

> **NCT00163410** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 500 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00163410
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 500 (—)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163410, "Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00163410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*